Status:
COMPLETED
Xirtam H Combination In the Treatment of Hypertension Evaluation Study.
Lead Sponsor:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This is post-marketing observational study in which data on safety and effectiveness of Xirtam H will be collected from routine clinical practice. The study objectives are to investigate the effect of...
Eligibility Criteria
Inclusion
- All Indian hypertensive patients (Blood pressure \> 140/90 mm Hg) where investigator feels that addition of Xirtam H would be beneficial to patients will be included in non interventional study.
Exclusion
- Exclusion criteria must be read in conjunction with corresponding product prescribing information
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
8704 Patients enrolled
Trial Details
Trial ID
NCT01219556
Start Date
November 1 2010
End Date
February 1 2013
Last Update
January 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, India